# Successful treatment and remission of advanced testicular cancer after COVID‐19 infection during induction chemotherapy

## TL;DR

A man with advanced testicular cancer achieved remission after continuing chemotherapy shortly after a mild case of COVID-19.

## Contribution

This case highlights successful cancer treatment despite a concurrent mild COVID-19 infection during chemotherapy.

## Key findings

- Chemotherapy was resumed with only a 1-day delay after a mild COVID-19 diagnosis.
- The patient achieved remission with minimal disruption to the treatment schedule.
- The case supports individualized decisions for resuming cancer treatment after mild COVID-19.

## Abstract

We report a case of advanced testicular cancer cured by early and appropriate resumption of chemotherapy even after COVID‐19 infection during induction chemotherapy.

The patient was a healthy 36‐year‐old male. The diagnosis was a stage IIIB nonseminoma (pT2N2M1a). On day 14 of the first chemotherapy cycle, the patient was diagnosed with mild COVID‐19. The second chemotherapy cycle was initiated with a 1‐day delay (on day 10 after the COVID‐19 diagnosis). The patient achieved remission with minimal postponement of chemotherapy.

Only a few case reports have described the resumption of anticancer chemotherapy in patients with COVID‐19. In deciding when to resume chemotherapy after COVID‐19 infection, it is essential to consider factors such as cancer type, progression, and severity of COVID‐19 and should be tailored to individual patient needs.